Deutsche Takes A Look At Johnson & Johnson's Patent Woes

By: via Benzinga
Deutsche Bank maintained its Buy rating on Johnson & Johnson (NYSE: JNJ) despite a federal judge invalidated the company's ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.